Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Accounts payable and accrued liabilities | 11,563 | 12,747 |
| Net cash provided by operating activities | 99,164 | 70,669 |
| Cash Flows From Investing Activities: | ||
| Purchases and construction of property, plant, and equipment | (18,098) | (21,262) |
| Purchase of intangible assets | — | (2,250) |
| Purchase of investments | (31,790) | (15,619) |
| Maturity of investments | 79,819 | 51,322 |
| Deposits and other assets | (1,794) | (2,335) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's capex?
- Amphastar Pharmaceuticals (AMPH) reported capex of $8.59M in Q2 2026.
- How has Amphastar Pharmaceuticals's capex changed year-over-year?
- Amphastar Pharmaceuticals's capex decreased by 18.7% year-over-year, from $10.57M to $8.59M.
- What is the long-term trend for Amphastar Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's capex has grown at a 6.2% compound annual growth rate (CAGR), from $27.46M to $34.88M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Amphastar Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude